Covidien PLC (NYSE:COV)
During the Trading Day
| 65.25 |  -0.55 / -0.84% |
Data as of 4:02pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 65.85 |  +0.60 / +0.92% |
Volume: 25.0K |
Latest COV News | Press Releases
| FDA Nod for COV's Advanced Nellcor - Analyst Blog May 21 / Zacks.com | Covidien Prices Senior Notes - Analyst Blog May 16 / Zacks.com |
| Covidien PLC (COV): Today's Featured Health Services Laggard May 16 / TheStreet.com | Masimo Wins a Major Turkish Client - Analyst Blog May 13 / Zacks.com |
Today’s Trading
| Previous close | 65.80 |
| Today’s open | 65.86 |
| Day’s range | 65.11 - 67.26 |
| Volume | 2,726,420 |
| Average volume (3 months) | 2,518,009 |
| Market cap | $31.0B |
| Dividend yield | 1.59% |
Data as of 4:02pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | +3.40% |
| Earnings growth (this year) | +3.37% |
| Earnings growth (next 5 years) | +8.50% |
| Revenue growth (last year) | +2.40% |
| P/E ratio | -- |
| Price/Sales | 2.41 |
| Price/Book | 2.94 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SYKStryker Corp | -1.54 | -2.22% |
| BDXBecton Dickinson and... | -0.99 | -0.98% |
| BSXBoston Scientific Co... | -0.10 | -1.08% |
| ZMHZimmer Holdings Inc | -1.15 | -1.42% |
Data as of 4:01pm ET, 05/22/2013
Financials
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | $1.11 |
| Annual revenue (last year) | $11.9B |
| Annual profit (last year) | $1.9B |
| Net profit margin | 16.05% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer José E. Almeida |
Senior Vice President-Quality & Operations Michael Sgrignari |
Corporate headquarters Dublin, Dublin |
Forecasts
